OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Urolithin A Hijacks ERK1/2‐ULK1 Cascade to Improve CD8+ T Cell Fitness for Antitumor Immunity
Shuaiya Ma, Qi Wu, Wenxian Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 8
Shuaiya Ma, Qi Wu, Wenxian Wu, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 8
Showing 8 citing articles:
Harnessing phytochemicals: innovative strategies to enhance cancer immunotherapy
Qianru Zhu, Ruonan Zhang, Min Jin Ha, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101206-101206
Open Access | Times Cited: 1
Qianru Zhu, Ruonan Zhang, Min Jin Ha, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101206-101206
Open Access | Times Cited: 1
Urolithin A Enhances Tight Junction Protein Expression in Endothelial Cells Cultured In Vitro via Pink1-Parkin-Mediated Mitophagy in Irradiated Astrocytes
Gengxin Lu, Junyu Wu, Zhihui Zheng, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access | Times Cited: 1
Gengxin Lu, Junyu Wu, Zhihui Zheng, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access | Times Cited: 1
Bioengineering the metabolic network of CAR T cells with GLP-1 and Urolithin A increases persistence and long-term anti-tumor activity
Areej Akhtar, Md Shakir, Mohammed Saleh Al Ansari, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 3, pp. 102021-102021
Open Access
Areej Akhtar, Md Shakir, Mohammed Saleh Al Ansari, et al.
Cell Reports Medicine (2025) Vol. 6, Iss. 3, pp. 102021-102021
Open Access
Immune response against Epstein-Barr virus as an etiologic factor and therapeutic target for multiple sclerosis
Vladimir Rogovskii, A. D. Kukushkina, A. N. Boyko
(2025) Vol. 27, Iss. 1, pp. 43-49
Closed Access
Vladimir Rogovskii, A. D. Kukushkina, A. N. Boyko
(2025) Vol. 27, Iss. 1, pp. 43-49
Closed Access
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells
Meiqi Yang, Shuling Zhang, Li Sun, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Meiqi Yang, Shuling Zhang, Li Sun, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
Jiayi Xie, Melody Smith
Blood (2024) Vol. 144, Iss. 15, pp. 1557-1569
Closed Access | Times Cited: 1
Jiayi Xie, Melody Smith
Blood (2024) Vol. 144, Iss. 15, pp. 1557-1569
Closed Access | Times Cited: 1
Optimizing CD8+ T cell-based immunotherapy via metabolic interventions: a comprehensive review of intrinsic and extrinsic modulators
Zihao Zhou, Jiarong Zheng, Ye Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Zihao Zhou, Jiarong Zheng, Ye Lu, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
